CXCR2 and chondrosarcoma: Specific simultaneous inhibition of CXCR1 and CXCR2 using blocking antibodies in human primary chondrocytes (figure 4A), or by siRNA in the JJ012 human chondrosarcoma cell line (figure 4B), resulted in reduced ECM production in micromass cultures.